For instance, based on the interquartile range, some cancers, such as liver hepatocellular carcinoma (LIHC), sarcoma (SARC) and COADREAD, had a widespread range of RET expression, while others—like TGCT, THCA and glioblastoma multiforme (GMB)—did not. This evidence concerns the gene RET and glioblastoma.